PH30761A - An infant formulation fortified with bile salt-activated lipase. - Google Patents

An infant formulation fortified with bile salt-activated lipase.

Info

Publication number
PH30761A
PH30761A PH43285A PH43285A PH30761A PH 30761 A PH30761 A PH 30761A PH 43285 A PH43285 A PH 43285A PH 43285 A PH43285 A PH 43285A PH 30761 A PH30761 A PH 30761A
Authority
PH
Philippines
Prior art keywords
bssl
fortified
bile salt
sequence given
activated lipase
Prior art date
Application number
PH43285A
Other languages
English (en)
Inventor
Bjursell Gunner
Blackberg Lars
Olivecrona Thomas
Herell Olle
Carlson Peter
Nilsson Jeanette
Enerback Sven
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of PH30761A publication Critical patent/PH30761A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/596Mixtures of surface active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH43285A 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase. PH30761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
PH30761A true PH30761A (en) 1997-10-17

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43285A PH30761A (en) 1990-06-01 1991-10-11 An infant formulation fortified with bile salt-activated lipase.

Country Status (44)

Country Link
EP (1) EP0535048B1 (pt)
JP (1) JPH05507201A (pt)
KR (1) KR100212411B1 (pt)
CN (2) CN1075113C (pt)
AP (1) AP207A (pt)
AT (1) ATE151077T1 (pt)
AU (1) AU651979B2 (pt)
BG (1) BG61165B1 (pt)
CA (1) CA2083396C (pt)
CZ (1) CZ287470B6 (pt)
DE (1) DE69125489T2 (pt)
DK (1) DK0535048T3 (pt)
DZ (1) DZ1503A1 (pt)
EG (1) EG19937A (pt)
ES (1) ES2099159T3 (pt)
FI (1) FI114639B (pt)
GR (1) GR3023618T3 (pt)
HK (1) HK62497A (pt)
HR (1) HRP920771B1 (pt)
HU (1) HU215258B (pt)
IE (1) IE911844A1 (pt)
IL (1) IL98273A (pt)
IS (1) IS1751B (pt)
JO (1) JO1694B1 (pt)
LT (1) LT4020B (pt)
LV (1) LV10292B (pt)
MA (1) MA22166A1 (pt)
MY (1) MY111245A (pt)
NO (1) NO322962B1 (pt)
NZ (1) NZ238223A (pt)
PH (1) PH30761A (pt)
PL (1) PL166534B1 (pt)
PT (1) PT97836B (pt)
RO (1) RO114793B1 (pt)
RU (1) RU2140983C1 (pt)
SE (1) SE9001985D0 (pt)
SG (1) SG48078A1 (pt)
SK (1) SK281089B6 (pt)
TN (1) TNSN91041A1 (pt)
TW (1) TW221712B (pt)
UA (1) UA39165C2 (pt)
WO (1) WO1991018923A1 (pt)
YU (1) YU49138B (pt)
ZA (1) ZA913778B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930935A2 (en) * 1992-06-11 1994-12-31 Astra Ab New dna sequences
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (en) * 2005-12-01 2008-09-03 University of Bergen Diagnosis and treatment of exocrine pancreatic dysfunction and diabetes using human cel gene
CN105214076B (zh) 2010-04-23 2020-03-31 辛那杰瓦生物制药股份有限公司 溶酶体贮积病酶
MX2013002704A (es) 2010-09-09 2013-09-13 Synageva Biopharma Corp Uso de acido lipasa lisosomal para tratar la deficiencia de acido lipasa lisosomal en pacientes.
CA2812852A1 (en) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Method to increase the absorption of unsaturated fatty acids by human infants
JP5850940B2 (ja) * 2010-10-21 2016-02-03 スウェディッシュ オーファン バイオビトラム パブリーク アクチエボラグ ヒト乳児の発育速度を増大させる方法
CA3066521A1 (en) * 2017-06-19 2018-12-27 Swedish Orphan Biovitrum Ab (Publ) Fusion protein with half-life extending polypeptide
MX2022002473A (es) 2019-08-30 2022-08-02 Codexis Inc Variantes de lipasa modificadas geneticamente.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60501758A (ja) * 1983-07-01 1985-10-17 セルテク リミテツド タンパク質、医薬構成物、遺伝子、ベクタ−宿主生物及びそれらの生産方法

Also Published As

Publication number Publication date
IL98273A (en) 2005-11-20
JPH05507201A (ja) 1993-10-21
HK62497A (en) 1997-05-16
RO114793B1 (ro) 1999-07-30
BG97123A (bg) 1993-12-24
DE69125489T2 (de) 1997-08-14
SE9001985D0 (sv) 1990-06-01
LTIP1736A (en) 1995-08-25
EP0535048A1 (en) 1993-04-07
CA2083396A1 (en) 1991-12-02
SK281089B6 (sk) 2000-11-07
CZ287470B6 (cs) 2000-12-13
FI925453A0 (fi) 1992-11-30
IE911844A1 (en) 1991-12-04
GR3023618T3 (en) 1997-08-29
LV10292A (lv) 1994-10-20
MY111245A (en) 1999-10-30
IL98273A0 (en) 1992-06-21
CN1075113C (zh) 2001-11-21
CA2083396C (en) 2006-09-19
CN1326782A (zh) 2001-12-19
KR100212411B1 (en) 1999-08-02
HU9203774D0 (en) 1993-03-29
PL166534B1 (pl) 1995-05-31
MA22166A1 (fr) 1991-12-31
HRP920771A2 (en) 1997-04-30
TNSN91041A1 (fr) 1992-10-25
BG61165B1 (bg) 1997-01-31
NO924528L (no) 1992-11-24
AU7964591A (en) 1991-12-31
CZ164491A3 (cs) 1999-07-14
LT4020B (en) 1996-08-26
ZA913778B (en) 1992-02-26
AP207A (en) 1992-08-18
NO322962B1 (no) 2006-12-18
TW221712B (pt) 1994-03-11
AP9100270A0 (en) 1991-07-31
DK0535048T3 (da) 1997-09-29
HRP920771B1 (en) 1999-10-31
ES2099159T3 (es) 1997-05-16
EG19937A (en) 2000-12-31
UA39165C2 (uk) 2001-06-15
SK164491A3 (en) 1995-07-11
PT97836A (pt) 1992-02-28
HU215258B (hu) 1998-11-30
WO1991018923A1 (en) 1991-12-12
FI925453A (fi) 1992-11-30
YU95191A (sh) 1994-06-10
CN1064313A (zh) 1992-09-09
PT97836B (pt) 1998-11-30
SG48078A1 (en) 1998-04-17
HUT63184A (en) 1993-07-28
IS3710A7 (is) 1991-12-02
NO924528D0 (no) 1992-11-24
DE69125489D1 (de) 1997-05-07
IS1751B (is) 2000-07-21
NZ238223A (en) 1993-05-26
AU651979B2 (en) 1994-08-11
LV10292B (en) 1995-08-20
DZ1503A1 (fr) 2004-09-13
EP0535048B1 (en) 1997-04-02
ATE151077T1 (de) 1997-04-15
YU49138B (sh) 2004-03-12
JO1694B1 (en) 1992-08-09
FI114639B (fi) 2004-11-30
RU2140983C1 (ru) 1999-11-10

Similar Documents

Publication Publication Date Title
PH30761A (en) An infant formulation fortified with bile salt-activated lipase.
WO1998014592A3 (en) Telomerase reverse transcriptase
CA2144312A1 (en) Unsaturated aliphatic dicarboxylic acids
AU2738497A (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
EP2172216A3 (en) Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
HU9403815D0 (en) Protective, nutritive and/or firming composition for the simultaneous treatment of the surface layers and deep layers of the skin, and use thereof
CA2137378A1 (en) D-enzyme compositions and methods of their use
AU1770888A (en) Treatment of periodontal disease
AU581662B2 (en) Cosmetic preparation
CA2278028A1 (en) Methods for improving transformation efficiency
CA2247336A1 (en) Parapoxviruses containing foreign dna, their production and their use in vaccines
AU2670495A (en) Ifn-beta liquid formulations
EP0293766A3 (en) Emulsified compositions
EP1591528A3 (en) Method and compositions for delivery and expression of interferon-alpha nucleic acids
IT8847640A0 (it) Dispositivo per la conservazione prolungata di prodotti al riparo dall'ossigeno dell'aria
EP0919621A4 (en) TAK1 HUMAN AND DNA ENCODING IT
EP0317279A3 (en) Peptides for use in the purification of factor viii
AU3333399A (en) Nucleotide sequence expressing human fatty acid transport protein and corresponding aminoacid sequence. use for the regulation of fatty acids metabolism
Gharavi Molecular cloning of the human lipoxygenase gene
Gautam Ultrafiltration of salted acid whey
Dodd Power and Knowledge in the Fiction of JM Coetzee
Tangley et al. Soviet Science
Arnold Serine-lactones in syntheses of amino acids
WO2001036458A3 (en) Drosophila ced-6 homologue
IT8820978A0 (it) Composizione erbicida conselettivita' aumentata e processo per la preparazione di entrambi i componenti ingredienti attivi in un solo stadio.